Clinical Trials Browser

Terminated × Adenocarcinoma × regorafenib × Clear all

NCT03722108 2023-10-16

REGIRI

Phase 1/2 Terminated

Adenocarcinoma

NCT02119676 2018-02-13

Study of Ruxolitinib in Colorectal Cancer Patients

Phase 2 Terminated

396 enrolled 15 charts

Gastrointestinal

Adenocarcinoma, Colonic Neoplasms, Colorectal Neoplasms